Week Ending August 15, 2022

Hepatitis C Reinfection Rates Low After Successful Treatment in People Who Inject Drugs
“Treatment of hepatitis C virus (HCV) with direct-acting antiviral medications was associated with low HCV reinfection rates among patients who inject drugs, although risk for reinfection was highest in the first 24 weeks of treatment and among those with ongoing injecting drug use.”

Only 41% of Pregnant People Were Screened for Hepatitis C in 2021
“Although hepatitis C screening rates for pregnant people have increased since the advent of new guidelines recommending universal screening during each pregnancy, less than half received the recommended tests in early 2021, according to study results published in Obstetrics and Gynecology. People insured through Medicaid were even less likely to be screened.”

CDC recommends increasing timely access to hepatitis C treatment 
“Fewer than one in three people with health insurance receive direct-acting antiviral treatment for hepatitis C within a year of diagnosis, ranging from 23% of Medicaid enrollees to 35% of people with private insurance, according to a report released today by the Centers for Disease Control and Prevention. Adults under 40 had the highest rate of new infections by age, most commonly through injection drug use, but are least likely to receive treatment, CDC said.”

Hepatitis C Treatment Rates Reveal Care Disparities in Public, Private Coverage
“Care disparities for hepatitis C may result in differences in timely diagnosis and treatment based race, age, coverage type, and gender.”

Few insured individuals receive timely direct-acting antiviral treatment for hepatitis C
“Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment, according to research published in the Aug. 9 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.”

Vertical Transmission of Hepatitis C Is Higher Than Previously Reported
“Hepatitis C virus (HCV) can be transmitted from mothers to their babies during pregnancy or gestation. The risk of vertical transmission was previously thought to be around 5% to 6% in women with HCV alone; it is higher in those with HIV coinfection. But methods of measuring perinatal transmission are not firmly established, and this may be an underestimate.”

VIDEO
CDC Vital Signs: Too Few People Being Treated for Hepatitis C